Network background and aims Why has NADA created this network? Gender and sexuality diverse (GSD) people are a priority in the National Drug Strategy, and other strategies related to AOD use. Notably, research demonstrates a, ‘higher prevalence of AOD use by lesbian, gay, bisexual, transgender and queer (LGBTQ) people, riskier use and a higher proportion […]
Advocate: CEO report
As we come to the end of 2020, we reflect on the year we’ve had. Bushfires, COVID-19, and the departure of long serving NADA CEO, Mr Larry Pierce. Larry has been instrumental in putting NADA in the position we are today, and I feel privileged to take over in representing and progressing the interests of […]
